Perceived risk and representations of cardiovascular disease (CVD), and preventive behaviour of people diagnosed with Familial Hypercholesterolemia by DNA testing (N = 81) were assessed. In general, participants perceived their own CVD risk as being relatively low. While participants reported almost optimal medication adherence (99%), only 49 per cent reported following recommendations concerning diet and physical activity. Family history of CVD was associated with both risk perception and the adoption of a healthy lifestyle. In their communications with FH-screened positives, health professionals should be aware that people may underestimate CVD risk, and should stress how behaviour change can reduce the risk.
Alper, J.S., & Beckwith, J. ( 1993). Genetic fatalism and social policy: The implications of behavior genetics research. Yale Journal of Biology and Medicine, 66, 511-524.
2.
Austin, M.A., Hutter, C.M., Zimmern, R.L., & Humphries, S.E. (2004). Familial hypercholesterolemia and coronary heart disease: A HuGE association review. American Journal of Epidemiology, 160, 421-429.
3.
Brewer, N.T., Chapman, G.B., Gibbons, F.X., Gerard, M., McCaul, K.D., & Weinstein, N.D. (2007). A meta-analysis of the relationship between risk perception and health behavior: The example of vaccination . Health Psychology, 26, 136-145.
4.
Burke, L.E., Dunbar-Jacob, J.M., & Hill, M.N. ( 1997). Compliance with cardiovascular disease prevention strategies: A review of the research. Annals of Behavioral Medicine, 19, 239-263.
5.
Cameron, L.D. ( 2003). Conceptualizing and assessing risk perceptions: A self-regulatory perspective. Paper presented at the Conceptualizing and Measuring Risk Perceptions Workshop. Washington, DC : Division of Cancer Control and Population Sciences, National Cancer Institute. dccps.nci.nih.gov/brp/conceptual.html (accessed 21 July 2008).
6.
Cameron, L. ( 2008). Illness risk representations and motivations to engage in protective behavior: The case of skin cancer risk. Psychology and Health, 23, 91-112.
7.
Civeira, F. ( 2004). Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis, 173, 55-68.
8.
Collins, F.S., Green, E.D., Guttmacher, A.E., & Guyer, M.S. ( 2003). A vision for the future of genomics research. Nature, 422, 835-847.
9.
Decruyenaere, M., Evers-Kiebooms, G., Welkenhuysen, M., Denayer, L., & Claes, E. ( 2000). Cognitive representations of breast cancer, emotional distress and preventive health behaviour: A theoretical perspective. Psycho-oncology, 9, 528-536.
10.
Hagger, M., & Orbell, S. ( 2003). A meta-analytic review of the common-sense model of illness representations. Psychology and Health, 18, 141-184.
11.
Hariri, S., Yoon, P.W., Qureshi, N., Valdez, R., Scheuner, M.T., & Khoury, M.J. ( 2006). Family history of type 2 diabetes: A population-based screening tool for prevention? Genetics in Medicine, 8, 102-108.
12.
JoJoGenetics. (2008). Lab protocol [online]. Sectie Moleculaire Diagnostiek van het Laboratorium Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum. http://www.jojogenetics.nl/site/protocol.htm (accessed 22 February 2008).
13.
Kaptein, A.A., van Korlaar, I.M., Cameron, L.D., Vossen, C.Y., van der Meer, F.J.M., & Rosendaal, F.R. (2007). Using the common-sense model to predict risk perception and disease-related worry in individuals at increased risk for venous thrombosis. Health Psychology , 26, 807-812.
14.
Leventhal, H., Benyamini, Y., & Brownlee, S. (1997). Illness representations: Theoretical foundations. In K. J. Petrie & J. Weinman (Eds.), Perceptions of health and illness, current research and applications (pp. 19-45). Amsterdam : Harwood Academic.
15.
Leventhal, H., Kelly, K., & Leventhal, E.A. (1999). Population risk, actual risk, perceived risk, and cancer control: A discussion. Journal of the National Cancer Institute, Monographs, 81-85.
16.
Marteau, T.M., & Lerman, C. ( 2001). Genetic risk and behavioural change. British Medical Journal, 322, 1056-1059.
17.
Marteau, T., Senior, V., Humphries, S.E., Bobrow, M., Cranston, T., Crook, M.A. et al. (2004). Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: A randomized controlled trial. American Journal of Medical Genetics, 128A, 285-293.
18.
Marteau, T.M., & Weinman, J. ( 2006). Self-regulation and the behavioural response to DNA risk information: A theoretical analysis and framework for future research. Social Science and Medicine, 62, 1360-1368.
19.
Mohrschladt, M.F., Westendorp, R.G.J., Gevers Leuven, J.A., & Smelt, A.H.M. ( 2004). Cardiovascular disease and mortality in statin-treated patients with Familial Hypercholesterolemia. Atherosclerosis , 172, 329-335.
20.
Moss-Morris, R., Weinman, J., Petrie, K.J., Horne, R., Cameron, L., & Buick, D. ( 2002). The revised illness questionnaire (IPQ-R). Psychology and Health, 17, 1-16.
21.
Rees, G., Fry, A., Cull, A., & Sutton, S. ( 2004). Illness perceptions and distress in women at risk of breast cancer. Psychology and Health, 19, 749-765.
22.
Senior, V., & Marteau, T.M. ( 2007). Causal attributions for raised cholesterol and perceptions of effective risk-reduction: Self-regulation strategies for an increased risk of coronary heart disease. Psychology and Health, 22, 699-717.
23.
Senior, V., Marteau, T.M., & Weinman, J. ( 2005). Perceptions of control over heart disease in people with an inherited predisposition to raised cholesterol. Psychology, Health and Medicine, 10, 16-30.
24.
Senior, V., Smith, J.A., Michie, S., & Marteau, T.M. ( 2002). Making sense of risk: An interpretative phenomenological analysis of vulnerability to heart disease. Journal of Health Psychology, 7, 157-168.
25.
Senior V., Marteau, T.M., & Weinman, J. ( 2004). Self-reported adherence to cholesterol-lowering medication in patients with Familial Hypercholesterolaemia: The role of illness perceptions . Cardiovascular Drugs and Therapy, 18, 475-481.
26.
Shiloh, S. ( 2006). Illness representations, self-regulation, and genetic counseling: A theoretical review. Journal of Genetic Counseling , 15, 325-337.
27.
Umans-Eckenhausen, M.A., Defesche, J.C., Sijbrands, E.J., Scheerder, R.L., & Kastelein, J.J. (2001). Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet, 357, 165-168.
28.
Umans-Eckenhausen, M.A., Sijbrands, E.J., Kastelein, J.J., & Defesche, J.C. (2002). Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation, Journal of the Medical Heart Association, 106, 3031-3036.
29.
Van Maarle, M.C., Stouthard, M.E., & Bonsel, G.J. ( 2003a). Risk perception of participants in a family-based genetic screening program on familial hypercholesterolemia. American Journal of Medical Genetics, 116A, 136-143.
30.
Van Maarle, M.C., Stouthard, M.E., & Bonsel, G.J. ( 2003b). Quality of life in a family based genetic cascade screening programme for familial hypercholesterolaemia: A longitudinal study among participants . Journal of Medical Genetics, 40, e3.
31.
Van Maarle, M.C., Stouthard, M.E., Marang-van de Mheen, P.J., Klazinga, N.S., & Bonsel, G.J. ( 2002). Follow up after a family based genetic screening programme for familial hypercholesterolaemia: Is screening alone enough?British Medical Journal, 324, 1367-1368.
32.
Van Oostrom, I., Meijers-Heijboer, H., Duivenvoorden, H.J., Brocker-Vriends, A.H., van Asperen, C.J., Sijmons, R.H. et al. (2007). The common sense model of self-regulation and psychological adjustment to predictive genetic testing: A prospective study. Psycho oncology, 16, 1121-1129.
33.
Weinstein, N.D. ( 1987). Unrealistic optimism about susceptibility to health problems: Conclusions from a community-wide sample. Journal of Behavioral Medicine, 10, 481-500.
34.
Windschitl, P.D. ( 2002). Judging the accuracy of a likelihood judgement: The case of smoking risk. Journal of Behavioral Decision Making, 15, 19-35.
